
Nektar Therapeutics
NKTRNASDAQ NMS - GLOBAL MARKETKey Statistics
Open
$64.98
Day High
$65.48
Day Low
$63.25
Prev. Close
$65.01
VolumeShares traded today.
927.35K
Avg. VolumeAverage daily volume.
—
Market CapTotal value of all shares = price × shares outstanding.
$2.19B
P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.
-7.71
Forward P/EP/E based on forecast next-year earnings.
—
P/B RatioPrice-to-Book: share price ÷ book value per share.
—
52W HighHighest price over the past 52 weeks.
$109.00
52W LowLowest price over the past 52 weeks.
$7.99
50D MAAverage closing price over the last 50 trading days.
$77.84
200D MAAverage closing price over the last 200 trading days.
$58.54
Dividend YieldAnnual dividend ÷ share price, as a %.
—
BetaVolatility vs the market. >1 = more volatile than the S&P 500.
—
Performance
1W
-5.4%1M
-22.0%6M
+7.5%YTD
+49.4%1Y
+443.1%About
Nektar Therapeutics is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California. The company develops new drug candidates by applying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances, which improves drug characteristics like retention and solubility. It is a technology supplier to a number of pharmaceutical companies including Affymax, Amgen, Merck, Pfizer and UCB Pharma, etc. The company developed the world's first inhalable non-injectable insulin, Exubera, which was awarded as the bronze award by Wall Street Journal for its technological breakthrough.
www.nektar.com/Company Facts
Similar stocks
Health CareSentiment
Latest News
Social Noise
Price Alerts
Loading…
Trade NKTR
Brokers available in your region (US)
Affiliate links — we may earn a commission. CFDs are risky.